>>Signaling Pathways>> Neuroscience>> Gap Junction>>Meclofenamate sodium

Meclofenamate sodium (Synonyms: Meclofenamic Acid)

Catalog No.GC38657

메클로페남산(메클로페나메이트) 나트륨은 관절염(골 및 류마티스), 진통(경증에서 중등도의 통증), 월경통 및 심한 월경 출혈(월경과다)에 사용하도록 승인된 비스테로이드성 항염증제(NSAID)입니다.

Products are for research use only. Not for human use. We do not sell to patients.

Meclofenamate sodium Chemical Structure

Cas No.: 6385-02-0

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$57.00
재고 있음
50mg
US$52.00
재고 있음
100mg
US$92.00
재고 있음
200mg
US$153.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com


고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Meclofenamic acid sodium is a nonsteroidal anti-inflammatory drug (NSAID) approved for use in arthritis (osteo and rheumatoid), analgesia (mild to moderate pain), dysmenorrhea, and heavy menstrual blood loss (menorrhagia). Meclofenamic acid sodium is a non-selective gap-junction blocker and a highly selective inhibitor of fat mass and obesity-associated (FTO) enzyme inhibitor[1][2][3].

[1]. Conroy MC, et al. Pharmacology, pharmacokinetics, and therapeutic use of meclofenamate sodium. Clin J Pain. 1991;7 Suppl 1:S44-8. [2]. Eleftheriou CG, et al. Meclofenamic acid improves the signal to noise ratio for visual responses produced by ectopicexpression of human rod opsin. Mol Vis. 2017 Jun 16;23:334-345. eCollection 2017. [3]. Huang Y, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 2015 Jan;43(1):373-84.

리뷰

Review for Meclofenamate sodium

Average Rating: 5 ★★★★★ (Based on Reviews and 32 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Meclofenamate sodium

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.